|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 305, Issue 2, 587-592, May 2003
Minneapolis Medical Research Foundation (D.E.K., D.S., M.G.L.,
P.R.P.); Hennepin County Medical Center (D.E.K., P.R.P.); Department of
Pharmacology, University of Minnesota Medical School (P.R.P.); College
of Pharmacy, University of Minnesota (D.E.K.); and School of Public
Health, University of Minnesota (A.D.C.) Minneapolis, Minnesota
Cigarette smoking during pregnancy is associated with a variety of
adverse fetal outcomes. Nicotine is a likely contributor to these
adverse effects, with fetal brain as one target organ. Vaccination of
adult male rats against nicotine has been shown to reduce nicotine
distribution to the brain. The current study examined whether
vaccination of female rats before pregnancy would reduce the
distribution to fetal brain of a single nicotine dose administered
during gestation. Female rats immunized with a nicotine conjugate
vaccine received a single dose of nicotine 0.03 mg/kg i.v. on
gestational day 16 to 22. Five minutes later, vaccinated rats had
substantially higher bound and lower unbound serum nicotine concentration and lower brain nicotine concentration than controls. Fetal brain nicotine concentration was reduced by 43% in vaccinated rats, comparable to the reduction in the maternal brain nicotine concentration. The whole-fetus nicotine concentration was not altered
by vaccination. A similar experiment was performed in which pregnant
rats were passively immunized with rabbit nicotine-specific IgG 7 or 21 mg/kg just before nicotine dosing. The effects of passive immunization
on nicotine distribution in the mother were IgG dose-related and the
higher dose reduced nicotine distribution to fetal brain by 60%. These
data suggest that vaccine effects on nicotine distribution to serum and
brain are similar in pregnant female rats to those previously reported
in adult males. Vaccination of female rats before pregnancy, or passive
immunization during pregnancy, can reduce the exposure of fetal brain
to a single dose of maternally administered nicotine.
This article has been cited by other articles:
![]() |
W. H. Frishman Smoking cessation pharmacotherapy Therapeutic Advances in Cardiovascular Disease, August 1, 2009; 3(4): 287 - 308. [Abstract] [PDF] |
||||
![]() |
C. L. Garwood and L. A. Potts Emerging pharmacotherapies for smoking cessation Am. J. Health Syst. Pharm., August 15, 2007; 64(16): 1693 - 1698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le, and P. R. Pentel MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS Drug Metab. Dispos., July 1, 2005; 33(7): 1056 - 1061. [Abstract] [Full Text] [PDF] |
||||